Arcellx is now part of Kite, a Gilead company. Kite is a global biopharmaceutical company based in Santa Monica, California, focused on achieving cures with cell therapy. For more information on Kite, please visit www.kitepharma.com and follow @KitePharma on LinkedIn for updates. Note: Comments on the Arcellx LinkedIn page are not actively monitored.
| Website | http://arcellx.com |
| Revenue | $107.9 million |
| Employees | 229 (200 on RocketReach) |
| Founded | 2015 |
| Address | 800 Bridge Pkwy, Redwood City, California 94065, US |
| Technologies |
JavaScript
,
HTML
,
PHP
+42 more
(view full list)
|
| Industry | Biotechnology Research, Biopharma, Biotechnology, Health Care, Science and Engineering, Pharmaceutical |
| Keywords | Cell Therapy, Innovative Therapies, Immunotherapy, Biotechnology, New Treatments, Clinical Stage, Cancer Treatment, Oncology, Pharmaceutical, Biopharma, Drug Development, T Cell Therapy, Cell Engineering, Gene Therapy, Regenerative Medicine, Precision Medicine, Clinical Trials, Therapeutics, Biologics |
| Competitors | Roche, Novartis, AbbVie, Merck & Co., Inc., Pfizer, Bristol Myers Squibb, Amgen, Regeneron, Gilead Sciences +42 more (view full list) |
Looking for a particular Arcellx employee's phone or email?
The Arcellx annual revenue was $107.9 million in 2026.
Aileen Fernandes is the COO of Arcellx.
200 people are employed at Arcellx.
Arcellx is based in Redwood City, California.